RARE icon

Ultragenyx Pharmaceutical
RARE

Overview Fund Activity

274 hedge funds and large institutions have $3.63B invested in Ultragenyx Pharmaceutical in 2024 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 117 increasing their positions, 80 reducing their positions, and 39 closing their positions.

Holders
274
Holders Change
+6
Holders Change %
+2.24%
% of All Funds
3.99%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
47
Increased
117
Reduced
80
Closed
39
Calls
$22.7M
Puts
$15M
Net Calls
+$7.77M
Net Calls Change
-$6.85M

Top Buyers

1
VPC
1
Vestal Point Capital
New York
$74M
2
Sands Capital Management
2
Sands Capital Management
Virginia
$220M
3
Millennium Management
3
Millennium Management
New York
$76.1M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$402M
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$46.2M

Top Sellers

1
RI
1
RTW Investments
New York
$134M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$123M
3
Pictet Asset Management
3
Pictet Asset Management
Switzerland
$22.9M
4
EAM
4
Eventide Asset Management
Massachusetts
$0
5
Mirae Asset Global Investments
5
Mirae Asset Global Investments
South Korea
$103K
Name Market Value Shares Shares
Change 		Shares
Change %
ACA
26
Avoro Capital Advisors
New York
$34.1M 830,000 – –
Bank of New York Mellon
27
Bank of New York Mellon
New York
$32.1M 781,943 -129,713 -14%
SSA
28
Schonfeld Strategic Advisors
New York
$29.5M 716,947 +276,149 +63%
CS
29
Candriam SCA
Luxembourg
$28.3M 688,942 +171,345 +33%
Fidelity Investments
30
Fidelity Investments
Massachusetts
$26.6M 647,618 -134,414 -17%
Jacobs Levy Equity Management
31
Jacobs Levy Equity Management
New Jersey
$26.1M 634,327 -53,292 -8%
Goldman Sachs
32
Goldman Sachs
New York
$25.9M 629,514 +265,392 +73%
Man Group
33
Man Group
United Kingdom
$25.8M 628,726 +475,085 +309%
Two Sigma Investments
34
Two Sigma Investments
New York
$23.4M 568,309 +152,995 +37%
Pictet Asset Management
35
Pictet Asset Management
Switzerland
$22.9M 556,818 -479,556 -46%
FAM
36
Fred Alger Management
New York
$22.6M 548,905 -32,646 -6%
Bank of America
37
Bank of America
North Carolina
$22.5M 547,818 +117,282 +27%
Point72 Asset Management
38
Point72 Asset Management
Connecticut
$22.2M 539,749 +478,849 +786%
Charles Schwab
39
Charles Schwab
California
$22.1M 537,616 +53,235 +11%
DCM
40
Driehaus Capital Management
Illinois
$21.7M 528,180 +138,889 +36%
EHI
41
Eagle Health Investments
Connecticut
$21.6M 524,500 +224,800 +75%
Morgan Stanley
42
Morgan Stanley
New York
$20.5M 497,969 -6,413 -1%
EA
43
Emerald Advisers
Pennsylvania
$20M 486,682 -1,456 -0.3%
Two Sigma Advisers
44
Two Sigma Advisers
New York
$18.2M 442,200 -6,000 -1%
Axa
45
Axa
France
$17.5M 425,334 +92,567 +28%
FLSM
46
Frazier Life Sciences Management
California
$17.5M 425,000 +425,000 New
Hudson Bay Capital Management
47
Hudson Bay Capital Management
Connecticut
$17.1M 415,000 +109,900 +36%
GKIM
48
GW&K Investment Management
Massachusetts
$16.7M 406,519 +103,142 +34%
Walleye Capital
49
Walleye Capital
New York
$16.1M 390,592 +123,951 +46%
EMFAT
50
Emerald Mutual Fund Advisers Trust
Pennsylvania
$16.1M 390,524 +5,184 +1%
1
2
3 4 5